The clinical efficacy of imiglucerase versus eliglustat in patients with Gaucher's disease Type 1: A systematic review

• Main Authors: Azita Nabizadeh (Author), Bahman Amani (Author), Maliheh Kadivar (Author), Mahdi Toroski (Author), Akbar Abdollahi Asl (Author), Yahya Bayazidi (Author), Mahdi Mojahedian (Author), Majid Davari (Author)
• Format: Book
• Published: Wolters Kluwer Medknow Publications, 2018-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Gaucher's disease (GD) is one of the most common lysosomal diseases in humans. It results from β-glucosidase deficiency and leads to necrosis, especially in macrophages with the accumulation of glucosylceramidase in cells. Most of the deleterious effects of the disease are seen in the liver, sp...